A Network Meta-Analysis Comparing Effects of Various Antidepressant Classes on the Digit Symbol Substitution Test (DSST) as a Measure of Cognitive Dysfunction in Patients with Major Depressive Disorder
Open accessThe DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
Abstract
Background: Major depressive disorder is a common condition that often includes cognitive dysfunction. A systematic literature review of studies and a network meta-analysis were carried out to assess the relative effect of antidepressants on cognitive dysfunction in major depressive disorder. Methods: MEDLINE, Embase, Cochrane, CDSR, and PsychINFO databases; clinical trial registries; and relevant conference abstracts were searched for randomized controlled trials assessing the effects of antidepressants/placebo on cognition. A network meta-analysis comparing antidepressants was conducted using a random effects model. Results: The database search retrieved 11337 citations, of which 72 randomized controlled trials from 103 publications met the inclusion criteria. The review identified 86 cognitive tests assessing the effect of antidepressants on cognitive functioning. However, the Digit Symbol Substitution Test, which targets multiple domains of cognition and is recognized as being sensitive to change, was the only test that was used across 12 of the included randomized controlled trials and that allowed the construction of a stable network suitable for the network meta-analysis. The interventions assessed included selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, and other non-selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors. The network meta-analysis using the Digit Symbol Substitution Test showed that vortioxetine was the only antidepressant that improved cognitive dysfunction on the Digit Symbol Substitution Test vs placebo {standardized mean difference: 0.325 (95% CI = 0.120; 0.529, P=.009}. Compared with other antidepressants, vortioxetine was statistically more efficacious on the Digit Symbol Substitution Test vs escitalopram, nortriptyline, and the selective serotonin reuptake inhibitor and tricyclic antidepressant classes. Conclusions: This study highlighted the large variability in measures used to assess cognitive functioning. The findings on the Digit Symbol Substitution Test indicate differential effects of various antidepressants on improving cognitive function in patients with major depressive disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Among 72 randomized controlled trials, vortioxetine showed a significant cognitive benefit over placebo (standardized mean difference = 0.325, p = 0.009) and was superior to escitalopram, nortriptyline, SSRIs, and tricyclic antidepressants.”
From Efficacy of Vortioxetine Versus Escitalopram on the Cognitive Profile of Patients With Depressive Disorder: A Comparative Study (2025) · cites this paper as [22]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Meanwhile, a network meta-analysis shows that Vortioxetine provides statistically significant improvements in cognitive function compared with other antidepressants, possibly due to its unique pharmacological profile.20”
From A Randomized Controlled Study of Efficacy and Cognitive Function Improvement of Vortioxetine and Escitalopram in Patients with Depression in Chinese Han Nationality (2024) · cites this paper as [20]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“A study of a larger scale comparing the effects of antidepressants on cognitive function measured by DSST demonstrated that Vortioxetine was more efficacious than Escitalopram and other antidepressants.20”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Zhang, Q., Wang, C., Zheng, M., Li, Y., Li, J., Zhang, L., Shang, X., & Yan, C. (2015) · Cerebrovascular Diseases · doi:10.1159/000369778 · Cited by 11,533
Projections of Global Mortality and Burden of Disease from 2002 to 2030
Mathers, C. D., & Loncar, D. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030442 · Cited by 11,386
Ferrari, A. J., Charlson, F. J., Norman, R. E., Patten, S. B., Freedman, G., Murray, C. J. L., Vos, T., & Whiteford, H. A. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001547 · Cited by 3,115
Cognitive impairment in depression: a systematic review and meta-analysis
Rock, P. L., Roiser, J. P., Riedel, W. J., & Blackwell, A. D. (2014) · Psychological Medicine · doi:10.1017/s0033291713002535 · Cited by 2,161 · cited 1×
“7 standardized mean differences below what would be normal, depending on disease state and cognitive domain (Rund et al., 2006; Lee et al., 2012; Rock et al., 2014).”
BackgroundDIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS, FIFTH EDITION
Abbas, A., & Aminoroaia, M. (2013) · Cited by 1,479
A meta-analysis of cognitive deficits in first-episode Major Depressive Disorder
Lee, R. S. C., Hermens, D. F., Porter, M. A., & Redoblado-Hodge, M. A. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.10.023 · Cited by 737
Sanchez, C., Asin, K. E., & Artigas, F. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.07.001 · Cited by 547 · cited 5×
“In addition, cognitive improvements with vortioxetine may be due to direct and/or indirect effects via serotonergic, noradrenergic, cholinergic, dopaminergic, and histaminergic systems (Elmaadawi et al., 2015; Sanchez et al., 2015).”
BackgroundInfluentialConradi, H. J., Ormel, J., & de Jonge, P. (2011) · Psychological Medicine · doi:10.1017/s0033291710001911 · Cited by 515
Cognitive functioning in major depression – a summary
Hammar, Å. (2009) · Frontiers in Human Neuroscience · doi:10.3389/neuro.09.026.2009 · Cited by 491
Cognitive impairment in major depression
Marazziti, D., Consoli, G., Picchetti, M., Carlini, M., & Faravelli, L. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.08.046 · Cited by 448
Katona, C., Hansen, T., & Olsen, C. K. (2012) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e3283542457 · Cited by 445 · cited 1×
“Vortioxetine, a novel antidepressant with multimodal activity, has shown evidence of cognitive benefit in animal models (Wallace et al., 2014; Sanchez et al., 2015) as well as in patients with MDD (Katona et al., 2012; McIntyre et al., 2014; Mahableshwarkar et al., 2015).”
BackgroundMcIntyre, R. S., Lophaven, S., & Olsen, C. K. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145714000546 · Cited by 433
The role of cognitive impairment in general functioning in major depression
Baune, B. T., Miller, R., McAfoose, J., Johnson, M., Quirk, F., & Mitchell, D. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2008.12.001 · Cited by 378 · cited 2×
“Patients with MDD often experience impairment in cognitive function in several domains, including executive functioning, processing speed, concentration/attention, learning, and memory (Porter et al., 2007; Hammar and Ardal, 2009; Baune et al., 2010; Beblo et al., 2011; National Academies of Sciences, 2015).”
BackgroundSelf-citationRosenblat, J. D., Kakar, R., & McIntyre, R. S. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv082 · Cited by 315 · cited 3×
“At least 3 recent reviews were conducted to investigate the effects of antidepressants on cognitive dysfunction (Baune and Renger, 2014; Keefe et al., 2014; Rosenblat et al., 2016).”
BackgroundResultMahableshwarkar, A. R., Zajecka, J., Jacobson, W., Chen, Y., & Keefe, R. S. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.52 · Cited by 307
Neuropsychological Impairment in Major Depression: Its Nature, Origin and Clinical Significance
Porter, R. J., Bourke, C., & Gallagher, P. (2007) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/00048670601109881 · Cited by 236
McIntyre, R., Harrison, J., Loft, H., Jacobson, W., & Olsen, C. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw055 · Cited by 185 · cited 21×
“In addition, a recent meta-analysis by McIntyre et al. included 3 randomized controlled trials (RCTs) and showed that vortioxetine significantly improved cognition measured by the Digit Symbol Substitution Test (DSST), independent of changes in overall depressive symptoms (McIntyre et al., 2016).”
BackgroundMethodResultInfluentialBaune, B. T., & Malhi, G. S. (2015) · Bipolar Disorders · doi:10.1111/bdi.12341 · Cited by 177
Self-citationMcIntyre, R. S., Soczynska, J. K., Woldeyohannes, H. O., Alsuwaidan, M. T., Cha, D. S., Carvalho, A. F., Jerrell, J. M., Dale, R. M., Gallaugher, L. A., Muzina, D. J., et al. (2014) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2014.08.051 · Cited by 171
Health-Related Quality of Life in Depression: A Star*D Report
Daly, E. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Gaynes, B. N., Warden, D., Morris, D. W., Luther, J. F., Farabaugh, A., Cook, I., et al. (2010) · Annals of Clinical Psychiatry · doi:10.1177/104012371002200107 · Cited by 168
Buchanan, R. W., Keefe, R. S. E., Umbricht, D., Green, M. F., Laughren, T., & Marder, S. R. (2011) · Schizophrenia Bulletin · doi:10.1093/schbul/sbq038 · Cited by 154
Beblo, T., Sinnamon, G., & Baune, B. T. (2011) · Neuropsychology Review · doi:10.1007/s11065-011-9171-0 · Cited by 128 · cited 1×
“Patients with MDD often experience impairment in cognitive function in several domains, including executive functioning, processing speed, concentration/attention, learning, and memory (Porter et al., 2007; Hammar and Ardal, 2009; Baune et al., 2010; Beblo et al., 2011; National Academies of Sciences, 2015).”
BackgroundSelf-citationBaune, B. T., & Renger, L. (2014) · Psychiatry Research · doi:10.1016/j.psychres.2014.05.013 · Cited by 115 · cited 5×
“At least 3 recent reviews were conducted to investigate the effects of antidepressants on cognitive dysfunction (Baune and Renger, 2014; Keefe et al., 2014; Rosenblat et al., 2016).”
BackgroundResultInfluentialSelf-citationNeuropsychological test profiles in schizophrenia and non‐psychotic depression
Rund, B. R., Sundet, K., Asbjørnsen, A., Egeland, J., Landrø, N. I., Lund, A., Roness, A., Stordal, K. I., & Hugdahl, K. (2006) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2005.00626.x · Cited by 112
Cognitive Effects of Pharmacotherapy for Major Depressive Disorder: A Systematic Review
Keefe, R. S. E., McClintock, S. M., Roth, R. M., Doraiswamy, P. M., Tiger, S., & Madhoo, M. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13r08609 · Cited by 107
Wallace, A., Pehrson, A. L., Sánchez, C., & Morilak, D. A. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145714000571 · Cited by 97 · cited 2×
“Vortioxetine, a novel antidepressant with multimodal activity, has shown evidence of cognitive benefit in animal models (Wallace et al., 2014; Sanchez et al., 2015) as well as in patients with MDD (Katona et al., 2012; McIntyre et al., 2014; Mahableshwarkar et al., 2015).”
BackgroundDale, E., Zhang, H., Leiser, S. C., Xiao, Y., Lu, D., Yang, C. R., Plath, N., & Sanchez, C. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114543719 · Cited by 93
Pehrson, A. L., Leiser, S. C., Gulinello, M., Dale, E., Li, Y., Waller, J. A., & Sanchez, C. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.07.044 · Cited by 91
Prediction and prevention of suicide in patients with unipolar depression and anxiety
Gonda, X., Fountoulakis, K. N., Kaprinis, G., & Rihmer, Z. (2007) · Annals of General Psychiatry · doi:10.1186/1744-859x-6-23 · Cited by 74
Séguin, M., Lesage, A., Chawky, N., Guy, A., Daigle, F., Girard, G., & Turecki, G. (2006) · The Canadian Journal of Psychiatry · doi:10.1177/070674370605100906 · Cited by 65
Fournier, J. C., Keener, M. T., Almeida, J., Kronhaus, D. M., & Phillips, M. L. (2013) · Bipolar Disorders · doi:10.1111/bdi.12106 · Cited by 59
Tignol, J., Pujol‐Domenech, J., Chartres, J. P., Léger, J. ‐., Plétan, Y., Tonelli, I., Tournoux, A., & Pezous, N. (1998) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1998.tb09980.x · Cited by 52
The MMSE is not an adequate screening cognitive instrument in studies of late-life depression
Rajji, T. K., Miranda, D., Mulsant, B. H., Lotz, M., Houck, P., Zmuda, M. D., Bensasi, S., Reynolds, C. F., & Butters, M. A. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2008.06.002 · Cited by 43
Baune, B. T., Li, X., & Beblo, T. (2013) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803395.2013.824071 · Cited by 42
Self-citationUnderstanding and Managing Cognition in the Depressed Patient
Papakostas, G. I., & Culpepper, L. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13086ah1c · Cited by 39
Riga, M. S., Celada, P., Sánchez, C., & Artigas, F. (2013) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(13)70621-7 · Cited by 25
Jaeger, J., & Domingo, S. Z. (2016) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(16)31265-2 · Cited by 16
Prescriber's Guide to Using 3 New Antidepressants: Vilazodone, Levomilnacipran, Vortioxetine
Elmaadawi, A. Z., Singh, N., Reddy, J., & Nasr, S. J. (2015) · Current psychiatry · Cited by 7
Sciences, E. N. A. O. (2015) · National Academies Press eBooks · doi:10.17226/21745 · Cited by 5
Research works printed but not linked: 5
- European Medicines Agency, 2016, Brintellix summary of product characteristics
- Food and Drug Administration, 2016, Psychopharmacologic Drugs Advisory Committee: (PDAC) Meeting
- Haddjeri, 2012, Effects of the multimodal antidepressant Lu AA21004 on rat synaptic and cellular hippocampal plasticity and memory recognition, In: European Neuropsychopharmacology, 22, S303
- NICE, 2013, Specification for manufacturer/sponsor submission of evidence
- World Health Organization, 2016, Fact sheet N°369
Cited by
Jaeger, J. (2018) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000941 · Cited by 836
Marx, W., Penninx, B. W. J. H., Solmi, M., Furukawa, T. A., Firth, J., Carvalho, A. F., & Berk, M. (2023) · Nature Reviews Disease Primers · doi:10.1038/s41572-023-00454-1 · Cited by 768
HIV, Depression, and Cognitive Impairment in the Era of Effective Antiretroviral Therapy
Rubin, L. H., & Maki, P. M. (2019) · Current HIV/AIDS Reports · doi:10.1007/s11904-019-00421-0 · Cited by 178
O’Connor, E., Perdue, L. A., Coppola, E. L., Henninger, M. L., Thomas, R. G., & Gaynes, B. N. (2023) · JAMA · doi:10.1001/jama.2023.7787 · Cited by 126
Li, H., Sagar, A. P., & Kéri, S. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.08.021 · Cited by 102
Metadata
- Authors
- Baune, B. T., Brignone, M., & Larsen, K. G.
- Affiliations
- The University of Adelaide (AU)
- Lundbeck SAS, Issy-les-Moulineaux, France
- Lundbeck (Denmark) (DK)
- Corresponding author
- Brignone, Mélanie
- Venue
- International Journal of Neuropsychopharmacology
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-10-19
- Volume
- 21
- Issue
- 2
- Pages
- 97-107
- ISSN
- 1461-1457 (ISSN-L)
- 1469-5111
- PMC
- PMC5793828
- OpenAlex
- W2765333294
- Cited by
- 140
- References
- 42
- Citations by year
- 2026: 9 · 2025: 21 · 2024: 16 · 2023: 20 · 2022: 11 · 2021: 22 · 2020: 18 · 2019: 16 · 2018: 6 · 2017: 1
- FWCI
- 7.83
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- The International Journal of Neuropsychopharmacology (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion, cc-by-nc)
- Funders
- H. Lundbeck A/S and Takeda Pharmaceutical Company, Ltd
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- major depressive disorder, cognitive impairment, antidepressants, Digit Symbol Substitution Test, vortioxetine, selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, tricyclic antidepressants, escitalopram, nortriptyline
- MeSH terms
- Network Meta-Analysis, Antidepressive Agents, Depressive Disorder, Major, Major Depressive Disorder, Humans, Neuropsychological Tests, Cognitive Dysfunction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.